R
Roland E. Schmieder
Researcher at University of Erlangen-Nuremberg
Publications - 780
Citations - 85811
Roland E. Schmieder is an academic researcher from University of Erlangen-Nuremberg. The author has contributed to research in topics: Blood pressure & Essential hypertension. The author has an hindex of 97, co-authored 717 publications receiving 78138 citations. Previous affiliations of Roland E. Schmieder include Complutense University of Madrid & University of Regensburg.
Papers
More filters
Journal Article
Guía ESC/ESH 2018 sobre el diagnóstico y tratamiento de la hipertensión arterial
Bryan L. Williams,G. Mancia,Wilko Spiering,Enrico Agabiti Rosei,Michel Azizi,Michel Burnier,Denis Clement,Antonio Coca,Giovanni de Simone,Anna F. Dominiczak,Thomas Kahan,Felix Mahfoud,Josep Redón Más,Luis M. Ruilope,Alberto Zanchetti,Mary Kerins,Sverre E. Kjeldsen,Reinhold Kreutz,S. Laurent,Gregory Y.H. Lip,Richard J McManus,Krzysztof Narkiewicz,Frank Ruschitzka,Roland E. Schmieder,Evgeny Shlyakhto,Costas Tsioufis,Victor Aboyans,Ileana Desormais +27 more
TL;DR: Autores/Miembros del Grupo de Trabajo: Bryan Williams* (coordinador de la ESC) (Reino Unido), Giuseppe Mancia* ( coordininador oficial de la ESH) (Italia), Wilko Spiering (Países Bajos), Enrico Agabiti Rosei ( italia), Michel Azizi (Francia), Michel Burnier (Suiza)
Journal ArticleDOI
Patient preference for therapies in hypertension: a cross-sectional survey of German patients
TL;DR: This survey found that a significant proportion of patients would choose catheter-based RDN over lifelong pharmacotherapy, and these patients were younger and more likely to be male but their expectation of the extent of BP decrease with RDN was high.
Journal ArticleDOI
Blood Pressure Control in Patients With Comorbidities
TL;DR: There is a particular need for effective 24‐hour BP control in patients with obesity, diabetes, hyperlipidemia, or the metabolic syndrome, due to the increased likelihood of nondipping status, which is a risk factor for TOD and mortality.
Journal ArticleDOI
Effects of statin treatment on endothelial function, oxidative stress and inflammation in patients with arterial hypertension and normal cholesterol levels
TL;DR: Fluvastatin treatment did not improve endothelial function, oxidative stress or inflammation in patients with arterial hypertension and normal LDL-cholesterol levels, arguing against the usefulness of statins in patients in the absence of hypercholesterolemia or other additional risk factors.
Journal ArticleDOI
Assessment of endothelial function of the renal vasculature in human subjects
TL;DR: L-arginine at a dose of 100 mg/kg is sufficient to analyze endothelial function of the renal vasculature and the prolonged effect of L-NMMA and L- arginine must be taken into account in study protocols using both substances.